Vitamin C Deficiency: Signs, Symptoms, and Scurvy Today

Scurvy is not a disease of the past, but it is also almost certainly not what is making you tired.

The amount of vitamin C that prevents scurvy is tiny — around 10 mg a day, roughly a seventh of one orange. Yet hospital cases in wealthy countries have been climbing since 2020.

Both things are true at once, and the gap between them is where the useful information sits. This guide separates genuine deficiency from the much larger grey zone above it, because the signs, the causes and the fix are different for each.

Table of Contents

1. What Vitamin C Deficiency Actually Means
2. The Early Signs Are Quiet
3. What Scurvy Looks Like Today
4. Why Scurvy Still Appears in Wealthy Countries
5. Who Is Actually at Risk
6. Where Absorption Starts to Matter
7. Bio Absorb Nutraceuticals Liposomal Vitamin C
8. Frequently Asked Questions
9. Conclusion

1. What Vitamin C Deficiency Actually Means

"Deficiency" is not a feeling. It is a blood measurement, and the number is plasma vitamin C below 11.4 µmol/L. On that definition, 6.8% of US adults were deficient in 2017–2018, against 7.0% in 2003–2006 — no meaningful change across fifteen years.

Above that line sits a graded scale rather than a switch. Researchers analysing national survey data separate hypovitaminosis (11–23 µmol/L) from inadequate (23–49) and adequate (50–69) status, and 41.8% of the population falls somewhere below 50 µmol/L. That figure is often quoted as though it means deficiency. It does not.

The intake side is more striking. Overt deficiency symptoms appear only when intake drops below roughly 10 mg a day for many weeks, while the adult RDA is 90 mg for men and 75 mg for women. The RDA is set around nine times higher than the amount that keeps scurvy away.

That gap is deliberate. The RDA was never built to prevent scurvy; it was built around the intake that keeps white blood cells saturated and plasma near its natural ceiling, which human pharmacokinetic work places at roughly 100 to 200 mg a day. So falling below the RDA and being deficient are two genuinely different states, separated by roughly 80 mg of daily intake and a great deal of clinical distance.

2. The Early Signs Are Quiet

Long before anything shows on the skin, low vitamin C status looks like ordinary tiredness. A randomised, double-blind trial in 28 healthy men with plasma below 45 µmol/L gave 1,000 mg a day for eight weeks and measured a 39.6% rise in physical activity scores against placebo. The confidence interval crossed zero (p = 0.10), so treat that as suggestive rather than settled.

The symptoms most often reported at marginal status are frustratingly general:

• Fatigue and malaise, often for weeks with no clear trigger
• Low mood and irritability
• A reduced desire to be physically active
• Slower recovery from minor wounds and infections

Every one of those has dozens of more likely causes. That is exactly why a symptom checklist is a poor tool here, and why status is assessed by blood testing rather than by how someone feels. The more useful question is not "do I have these symptoms" but "what has my intake been for the last two months".

That question is answerable without a laboratory. Count the days in a typical week that include fruit, peppers, broccoli or leafy greens. Someone hitting the 75 to 90 mg RDA across most days is very unlikely to be building a deficit; someone managing two or three such days a week may be running well below it without noticing, because the body draws on stored reserves and the decline is gradual rather than abrupt.

3. What Scurvy Looks Like Today

A 2026 systematic review gathered 280 adult scurvy cases published between 2000 and 2025 across 35 countries. Of those, 112 (40%) came from the USA, 39 (13.9%) from France and 24 (8.6%) from Australia. The geography is the opposite of what most people expect.

The presentation is specific once it arrives. The 280-case review found purpura and corkscrew hairs dominating, alongside anaemia and bleeding. Clinical references add perifollicular haemorrhage, follicular hyperkeratosis, bleeding gums, poor wound healing and joint pain — a collagen failure showing up in every tissue that depends on it.

There is a reason those particular tissues fail. Vitamin C is a required cofactor for collagen synthesis, so when it runs out the body cannot build sound connective tissue — and collagen is the structural protein in blood vessel walls, gums, skin and the base of every hair follicle. Corkscrew hairs and pinpoint bleeding around follicles are not random symptoms; they are collagen failing in the smallest, most fragile structures first.

What makes it dangerous is that it imitates other things. The review found cases repeatedly worked up as autoimmune or bleeding disorders before anyone checked a diet history, and scurvy remains a clinical diagnosis rather than a laboratory one, since plasma below 0.2 mg/dL can be suggestive without being definitive.

4. Why Scurvy Still Appears in Wealthy Countries

France produced the clearest evidence. A nine-year national analysis of 888 children hospitalised with scurvy found a 34.5% cumulative rise in incidence after March 2020 (95% CI 12.7–56.3), alongside a 20.3% rise in severe malnutrition. Two unrelated control conditions showed no change over the same period.

The rise tracked the consumer price index. The United States shows a parallel pattern: a review of 19,413,465 paediatric inpatient records found scurvy incidence climbing from 8.2 per 100,000 in 2016 to 26.7 per 100,000 in 2020.

The mechanism is not mysterious. Fresh produce is the least shelf-stable and most price-sensitive part of a shopping basket, so it is the first thing squeezed out. Modern scurvy is a marker of food access rather than of knowledge, which is why it clusters with restrictive diets, isolation and unstable housing.

The wider picture is harder to see than it should be. A 2020 global review found hypovitaminosis C common in low- and middle-income countries and not uncommon in high-income ones, while flagging how few countries measure blood vitamin C at all. The United States has measured it in only three survey cycles since 2003, so national trend claims rest on a thinner evidence base than their confidence usually suggests.

5. Who Is Actually at Risk

Smoking is the single most consistent signal. Mean serum vitamin C runs 15 µmol/L lower in smokers than non-smokers, and an earlier national survey put adult smokers roughly one third below non-smokers. The RDA adds 35 mg a day for this reason, which is the background to why smokers need more vitamin C than non-smokers.

Age is more nuanced than it is usually presented. In the most recent national data, adults aged 60 and over averaged 8 µmol/L higher than those aged 20–59, not lower. Risk in older adults concentrates in specific circumstances — isolation, institutional catering, medication burden, a narrowed diet — rather than in age itself, which is the distinction that matters when considering how vitamin C status changes with age.

The remaining risk factors are largely economic and dietary:

• Low income — mean serum runs 8 µmol/L below the high-income group
• Obesity — 11 µmol/L lower than healthy weight
• Food insecurity and limited food variety
• Malabsorption conditions and heavy alcohol use

Two clinical situations sit apart from the rest. Malabsorption disorders and chronic illness can hold status low regardless of what someone eats, and heavy alcohol use both displaces food and impairs uptake. Across the 280 published adult cases, restrictive diets, social isolation and unstable housing recurred often enough that clinicians are advised to ask about circumstances, not just diet.

For most people none of these apply, and intake is the whole story. If you want to close a gap without supplementing, start with the foods that deliver the most vitamin C.

6. Where Absorption Starts to Matter

A landmark NIH depletion–repletion study hospitalised seven volunteers for four to six months on under 5 mg a day, then rebuilt their levels across doses from 30 to 2,500 mg. Plasma response followed a sigmoid curve, with the steep section between 30 and 100 mg a day, and white blood cells reached saturation at 100 mg daily while holding at least 14-fold more vitamin C than plasma — the reason vitamin C matters to immune function at all.

Past that point, efficiency drops away. The same study found bioavailability complete for a single 200 mg dose but declining above 500 mg, reaching roughly 33% at 1,250 mg. So at the intakes that prevent scurvy, absorption is a non-issue; it only becomes the limiting factor once someone is supplementing at doses well above the RDA.

The practical consequence is that one large dose is an inefficient way to raise status. Two things happen once the transporters saturate: a smaller share of the dose is absorbed at all, and whatever surplus does get absorbed is then excreted. Between them, the absorbed fraction falls to roughly 33% at 1,250 mg. Splitting the same daily total across two or three smaller doses works with that ceiling rather than against it.

That is the gap liposomal delivery targets. A 2025 scoping review of 10 trials found nine showing higher bioavailability, with AUC values 1.3–7.2-fold above non-liposomal forms, though the same review noted none assessed elimination and only two measured biological effects. The absorption advantage is well supported; whether it changes clinical outcomes in someone already replete has not been established, a distinction covered in our complete guide to liposomal vitamin C.

7. Bio Absorb Nutraceuticals Liposomal Vitamin C

Most commercial ascorbic acid is derived from corn, and very few liposomal brands address it. Bio Absorb Nutraceuticals makes Liposomal Vitamin C Liquid 1000mg (Corn-Free) and Liposomal Vitamin C Capsules 1000mg (Corn-Free) — the same formulation and allergen profile in two formats, both verified corn-free.

Beyond the corn question, both are non-GMO, gluten-free, nut-free, dairy-free and vegan. They are made in Canada in a GMP-certified facility, Health Canada–approved and non-irradiated, and third-party tested every batch with a certificate of analysis available on request.

The format choice is practical rather than technical. The liquid carries a natural orange flavour and mixes into water or juice, which suits flexible dosing. The capsules need no refrigeration and have no taste, which suits travel and routine. Both are covered by a 100% money-back guarantee, and empty bottles do not need to be returned.

Serving details, current pricing and the full product specification are on the product pages, where they stay current. None of this is a treatment for deficiency — anyone with signs of scurvy needs a clinician, not a supplement aisle.

Frequently Asked Questions

Can I be low on vitamin C without having scurvy?

Yes, and that is by far the more common situation. Roughly 41.8% of the US population sits below the 50 µmol/L sufficiency mark, but only a small fraction of those people are anywhere near the 11.4 µmol/L deficiency threshold. The wide band between the two is where most people live, and it produces no visible signs at all.

How long does it take to develop scurvy?

Longer than most people assume. Symptoms appear only after intake drops below roughly 10 mg a day for many weeks — the research protocol that reliably produces depletion held volunteers on under 5 mg a day for four to six months. A few weeks of poor eating will not do it.

Does constant fatigue mean I need more vitamin C?

Usually not. Fatigue is one of the earliest signals of low status, but it is also one of the least specific symptoms in medicine, and the trial evidence in men with plasma under 45 µmol/L did not reach statistical significance. If tiredness is persistent, it warrants a proper workup rather than a supplement.

Can I get my vitamin C level tested?

A plasma vitamin C test is available through most clinical laboratories, though it reflects recent intake more than long-term tissue stores. Leukocyte measurement tracks tissue status more accurately but needs specialised handling, so it is rarely offered outside research settings.

Do I need a supplement if I eat fruit and vegetables?

Most people meeting the 90 mg and 75 mg adult RDAs from food do not. Supplementation makes more sense for the groups with measurably elevated needs or reduced intake, above all smokers and people on low incomes, the two groups national survey data flags most consistently. Restrictive diets and limited food access belong on the same list.

How much vitamin C is too much?

The Tolerable Upper Intake Level for adults is 2,000 mg a day, above which gastrointestinal upset becomes common. Anyone with kidney disease, a history of kidney stones, an iron-overload condition such as haemochromatosis, or who takes regular medication should speak to a physician before supplementing.

Conclusion

Scurvy is real, rising in specific populations, and prevented by an amount of vitamin C so small it is almost hard to avoid. The more relevant question for most readers is not whether they are among the 6.8% who are deficient, but where they sit on the long gradient above that line. If supplementing is the answer for you, see the current serving details for Bio Absorb Nutraceuticals Liposomal Vitamin C.

Research References

1. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences USA, Vol. 93, Issue 8 (1996). In-hospital depletion–repletion study establishing the sigmoid dose–plasma relationship and the decline in bioavailability above 500 mg.
2. Vitamin C Status of US Adults Assessed as Part of the National Health and Nutrition Examination Survey Remained Unchanged between 2003–2006 and 2017–2018. The Journal of Applied Laboratory Medicine, Vol. 8, Issue 2 (2023). Source of the 6.8% deficiency prevalence and the smoking, income, sex and BMI differences in mean serum vitamin C.
3. Insufficient Vitamin C Levels among Adults in the United States: Results from the NHANES Surveys, 2003–2006. Nutrients, Vol. 13, Issue 11 (2021). Defines the five plasma status categories and reports that 41.8% of the population falls below the sufficiency threshold.
4. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003–2004 National Health and Nutrition Examination Survey. The American Journal of Clinical Nutrition, Vol. 90, Issue 5 (2009). Reference national analysis showing elevated deficiency risk among smokers and low-income adults.
5. Scurvy incidence trend among children hospitalised in France, 2015–2023: a population-based interrupted time-series analysis. The Lancet Regional Health — Europe, Vol. 49 (2024). Documents the 34.5% cumulative rise in paediatric scurvy after March 2020 and its correlation with the consumer price index.
6. The Troubling Rise of Scurvy: A Review and National Analysis of Incidence, Associated Risk Factors, and Clinical Manifestations. JAAOS: Global Research and Reviews, Vol. 8, Issue 7 (2024). US inpatient analysis showing paediatric scurvy incidence rising from 8.2 to 26.7 per 100,000 between 2016 and 2020.
7. Scurvy, an enduring mimicker and diagnostic dilemma in adults: A review of the 280 relevant published cases in the twenty-first century. Clinical Nutrition, Vol. 59 (2026). Systematic review of 280 adult cases across 35 countries, describing the dominant clinical features and the pattern of misdiagnosis.
8. Vitamin C Supplementation Slightly Improves Physical Activity Levels and Reduces Cold Incidence in Men with Marginal Vitamin C Status: A Randomized Controlled Trial. Nutrients, Vol. 6, Issue 7 (2014). Source for the non-specific early symptom profile and the non-significant activity result at marginal status.
9. Global Vitamin C Status and Prevalence of Deficiency: A Cause for Concern? Nutrients, Vol. 12, Issue 7 (2020). Global review of vitamin C status assessment and the limits of the available epidemiological base.
10. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137 (2025). Reports 1.3–7.2-fold higher AUC for liposomal forms in nine of ten trials, and the evidence gaps that remain.
11. Vitamin C — Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements. Source for the approximate 10 mg/day deficiency threshold, the adult RDAs, the additional 35 mg/day for smokers, and the 2,000 mg/day Tolerable Upper Intake Level.
12. Vitamin C Deficiency. StatPearls, National Center for Biotechnology Information (updated 2023). Clinical reference for the physical signs of scurvy and the relative merits of plasma versus leukocyte measurement.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.